Study: JNJ Reduces Risk Of Covid By Half

🚨 🚨 The single-dose COVID-19 vaccine from Johnson & Johnson (NYSE:JNJ) can reduce the risk of infection from the coronavirus by about half, a new study involving more than half a million healthcare workers in South Africa indicates
HumanQuant By HumanPotential – A Bespoke Algo Driven Investment Program Powered By 75% A.I. and 25% Human Intelligence
From A Blank Canvas, We Create Wealth With 90% Accuracy, Trading Equities, ETFs, Futures, FX and Cryptos. Risk Versus Reward Is Crafted To Suit Your Requirements
Talk To Us Today And Let Us Give You A Taste Of The Great Disruption: bit.ly/AlgoTrader OR bit.ly/AlgoFactory
AlgorithmicInvestment #AccuracyProfits #HumanQuant #JNJ

Leave a comment